Results 261 to 266 of about 3,352,681 (266)

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
exaly  

two-phase inclusions

2009
openaire   +1 more source

Two-Phase Locking

2011
openaire   +1 more source

inclusion, two-phase

2009
openaire   +1 more source

Two-Phase Flow

2004
openaire   +1 more source

Two-Phase Flow

2017
openaire   +1 more source